Program Book
Program Book
Program Book
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
not associated with severity of RB.<br />
Conclusions. Directing awareness campaigns to low SES groups may be<br />
of benefit in the UK but ethnicity was not a factor.<br />
Financial disclosure. None<br />
352 RBp113<br />
NEUROPSYCHOMOTOR DEVELOPMENT OF EYE<br />
ENUCLEATED CHILDREN WITH RETINOBLASTOMA<br />
Marcela Bagnatori Braga, Juliana dos Santos Soares, Carla R. Donato<br />
Macedo, Walquyria de Almeida Santos (mabagnatori@uol.com.br)<br />
Purpose. Retinoblastoma is the most common malignant ocular tumor<br />
of childhood, usually presenting before four years of age. The incidence<br />
in Brazil shows an average of 3 to 5 cases/million in children younger<br />
than 14 years old.<br />
Currently, the cure rates of Retinoblastoma are higher because<br />
of the advances in diagnosis and treatment. However, aesthetic,<br />
ophthalmologic, neurocognitive and social effects, as well as visual<br />
impairment, makes eye enucleated children with Retinoblastoma<br />
likely to show deficits in Neuropsychomotor Development and/or<br />
Sensory Integration. The Purpose is present the possible changes in<br />
Neuropsychomotor Development and/or Sensory Integration of eye<br />
enucleated children with Retinoblastoma.<br />
Methods. A study was made at the Pediatric Oncology Institute - GRAACC<br />
/ UNIFESP - São Paulo - Brazil. Two assessment tools were used, the<br />
PEDI and the Sensory Profile.<br />
Results. It was possible to check that children in this sample showed<br />
deficits in Neuropsychomotor Development and/or Sensory Integration.<br />
These changes were graduated from minimal to maximum – following<br />
the assessments used.<br />
Conclusions. From this study was contested an alteration in<br />
Neuropsychomotor Development and/or Sensory Integration of these<br />
children related to the disease, treatment and consequences in the<br />
sensorial and motor system of this population.<br />
Financial disclosure. None<br />
345 RBp114<br />
NURSING GUIDELINES FOR SELF-CARE OF PATIENTS<br />
WITH PROSTHETIC RETINOBLASTOMA: AN EXPERI-<br />
ENCE REPORT<br />
Juliana dos Santos Soares, Carla R.D. Macedo, Adriana M. Duarte<br />
(js_soares3@hotmail.com)<br />
Purpose. Retinoblastoma (RB) is a rare cancer in retina, representing<br />
about 4% of all malignancies of childhood. The treatment modalities<br />
include chemotherapy, focal therapy, radiation and enucleation,<br />
according to the stage of disease. Upon receiving news of the<br />
enucleation, child and family tend to be fragile and frightened by the<br />
surgical procedure, the change in self-image and lifestyle after surgery.<br />
In this context, the role of nurse has great value in educating the patient<br />
and family providing support to deal with the new situation. The Purpose<br />
is to report the experience lived by a Nurse at a Brazilian Hospital of<br />
Pediatric Oncology with the orientation of a child with RB and her family<br />
for self-care after enucleation.<br />
Methods. It is an experience report. About 19 queries were held with<br />
the child and her family immediately after enucleation indication and<br />
throughout the adaptation process in the period from September<br />
2010 to July 2011. With appropriate language for the child age and<br />
RETINOBLASTOMA<br />
Posters<br />
52<br />
parents understanding, graphics and ocular prosthesis models were<br />
used for explanation of the whole procedure and required care after<br />
enucleation.<br />
Results. Subjects discussed in the meetings varies since surgery<br />
procedure to prosthetic eye care. After 10 months of starting the treatment,<br />
child and family became more calm and confident when talking about the<br />
experience of enucleation. The child showed to be able to perform selfcare<br />
under supervision of her mother.<br />
Conclusions. The sections were productive, with effective participation<br />
of patient and parents. As a result of these encounters, a plan for<br />
systematic and individualized care was prepared, with quality, by<br />
identifying the real needs of the child submitted to enucleation and her family.<br />
Financial disclosure. None<br />
33 RBp115<br />
EYE SALVAGE RATE IN 166 PATIENTS WITH INTRAOC-<br />
ULAR RETINOBLASTOMA<br />
Luiz F. Teixeira1,2, Carla R. Donato Macedo2, Virginia L. L Torres1,2,<br />
Camila H. Hashimoto2, Rubens Belfort Neto1,2, Juliana dos Santos<br />
Soares2, Clelia M. Erwenne1,2 (luizfteixeira@hotmail.com)<br />
1. Depatment of Ophthalmology, Federal University of Sao Paulo-<br />
UNIFESP<br />
2. Pediatric Oncology Institute/GRAACC/UNIFESP<br />
Purpose. To evaluate the eye salvage rate in 166 patients with<br />
intraocular retinoblastoma.<br />
Methods. Retrospective review of 217 consecutive eyes with intraocular<br />
retinoblastoma (115 unilateral cases and 51 bilateral cases).<br />
Results. A total of 217 eyes, 9 group A eyes (4%), 22 group B eyes<br />
(10%), 17 group C eyes (8%), 53 group D eyes (24%) and 116 group E<br />
eyes (54%) were treated.<br />
112 eyes (52%), (10 eyes (19%) of group D and 102 eyes (88%) of group<br />
E) were treated with enucleation as primary treatment.<br />
Systemic chemotherapy and/or local therapy were performed as first<br />
treatment in 105 eyes (46%), (9 group A, 22 group B, 17 group C, 43<br />
group D and 14 group E). External beam radiotherapy (EBRT) was used<br />
for major tumor recurrence. Analysing conservative therapies the eye<br />
salvage rate considering all forms of treatments and excluding EBRT<br />
was respectively: 100%/100% for group A, 95%/95% for group B,<br />
88%/82% for group C, 49%/40% for group D and 28%/14% for group<br />
E.<br />
From 217 eyes diagnosed with intraocular disease, 70 eyes (32%) were<br />
saved.<br />
The final eye salvage rate was 100% for group A (n=9), 95% for group<br />
B (n=21), 88% for group C (n=15), 40% for group D (n=21) and 3% for<br />
group E (n=4).<br />
Conclusions. Advanced intraocular disease, group D and E represent<br />
more than 70% of the intraocular disease treated in our institution<br />
with a high rate of primary or secondary enucleation. Groups A, B and<br />
C present excellent outcomes but represent only 28% of the eyes.<br />
Financial disclosure. None<br />
933 RBp116<br />
SYSTEMIC CHEMOTHERAPY IN THE MANAGEMENT<br />
OF RETINOBLASTOMA<br />
John D. McKenzie1, Nisha Sachdev1, Sandra Staffieri1,4, Kary Suen1 , James<br />
E. Elder1,2, John Heath2,3, Peter Downie3 (jdmckenzieonline@gmail.com)